AllSight
Companies · ENOV · Orthopedic, Prosthetic & Surgical Appliances & Supplies

Enovis CORP (ENOV)

Enovis CORP (ENOV) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.

Enovis CORP (ENOV) stock — financials & valuation

Key numbers for Enovis CORP (ENOV): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.

AllSight quality score: 39/100 — a percentile rank of Enovis CORP’s fundamentals against Manufacturing peers, weakest on financial health. A quality ranking, not a price prediction.

Market cap$1.0B
P / S0.5×
EV / EBITDA7.2×
Gross margin61.1%
Operating margin-45.1%
Net margin-47.9%
Return on equity-74.6%
ROIC-38.8%
Revenue growth4.9%
Debt / equity0.9×
Dividend yield0.0%

Is Enovis CORP overvalued? P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.

Independent of the events above — derived from Enovis CORP’s own financial statements and shown as context, never as advice.

Sep 1, 2026€155M acquisition
Enovis buys eCential Robotics for €155M as 2027 margins take a hit
Aug 6, 2026
Adjusted EPS beat, revenue edged past estimates, guidance held steady
Related companies in Orthopedic, Prosthetic & Surgical Appliances & Supplies
Open live on AllSight — the whole market, decoded →

About AllSight · Editorial standards & method · Contact